Gonadal dysgenesis and bone metabolism (Q32111022)

6 July 2017

1 reference

title

Gonadal dysgenesis and bone metabolism (English)

1 reference

6 July 2017

1 reference

Breuil V

1

1 reference

6 July 2017

Euller-Ziegler L

series ordinal

2

1 reference

6 July 2017

language of work or name

1 reference

1 February 2001

1 reference

6 July 2017

1 reference

6 July 2017

68

1 reference

6 July 2017

1

1 reference

6 July 2017

26-33

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

6 July 2017

1 reference

7 January 2021

Sex steroids and the acquisition of bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mineral density during puberty in western Canadian children

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Role of growth hormone and sex steroids in achieving and maintaining normal bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

The actions and interactions of sex steroids and growth factors/cytokines on the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Androgens and their role in skeletal homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Osteopenia in Men with a History of Delayed Puberty

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Effect of excess endogenous androgens on bone density in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Sex steroids and bone density in premenopausal and perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Origin of Estrogen in Normal Men and in Women with Testicular Feminization*

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Estrogen deficiency is a potential cause for osteopenia in adult male patients with Noonan's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Orthopedic aspects of the XO (Turner's) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Skeletal demineralization in Turner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Radiologic abnormalities of the sternum in Turner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Osteoporosis in ovarian dysgenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mineral density in Turner's syndrome--a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Urinary total hydroxyproline excretion in patients with Turner's syndrome and Klinefelter's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mineral density in middle-aged women with Turner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Growth hormone therapy in patients with Turner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Turner syndrome adolescents receiving growth hormone are not osteopenic

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Combination growth hormone and estrogen increase bone mineralization in girls with Turner syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Androgen effects on bone metabolism: recent progress and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

The structural basis of bone fragility in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Osteoporosis and Klinefelter's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Bone mass and mineral metabolism in Klinefelter's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Site-specific effect of testosterone on bone mineral density in male hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Testosterone and bone loss in Klinefelter syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

The Influence of Testosterone Substitution on Bone Mineral Density in Patients with Klinefelter's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2800%2900235-9

7 January 2021

10.1016/S1297-319X(00)00235-9

Identifiers

DOI

1 reference

release_wo6wak6szjgjvmztt7zr2voflq

6 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wo6wak6szjgjvmztt7zr2voflq

24 November 2022

mapped directly with Wikidata item

1 reference